Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125082) titled 'Prospective Cohort Study on Alcohol-Associated Liver Disease in China' on May 21.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Hangzhou Xixi Hospital
Condition:
Alcoholic fatty liver disease
Intervention:
Alcoholic liver disease group:None
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2025-09-29
Target Sample Size: Alcoholic liver disease group:400;Normal group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=291317
Published by HT Digital Content Services with permission from Health Daily ...